Mechanism of Cardiac Arrhythmias
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Disturbances in Heart Rhythm
Dysrhythmias VI: Management of Dysrhythmias
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jul 19, 2026

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
Published on: July 7, 2016
Fred M Kusumoto1, Nora Goldschlager
1Electrophysiology and Pacing Service, Division of Cardiology, Department of Medicine, Lovelace Medical Center, University of New Mexoco, 5400 Gibson Blvd SE, Albuquerque, NM 87108, USA. fred.kusumoto@lovelace.com
No abstract available in PubMed .
12:45Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
Published on: December 11, 2017
08:43Advanced Cardiac Rhythm Management by Applying Optogenetic Multi-Site Photostimulation in Murine Hearts
Published on: August 26, 2021